Compare Agilent Technologies Inc (A) vs Tidewater Inc (TDW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Agilent Technologies Inc vs Tidewater Inc — how do they compare? Agilent Technologies Inc trades at $149.35 (market cap $42.00B), while Tidewater Inc trades at $91.5 (market cap $4.46B). The key difference: Agilent Technologies Inc is far larger — about 9.4× Tidewater Inc's market cap, and Agilent Technologies Inc pays a 0.69% dividend while Tidewater Inc pays none. Which is the better fit depends on your goals.
| A | TDW | |
|---|---|---|
Market Cap | $42.00B | $4.46B |
Sector | Health | Utilities |
52-Week High | $157.20 | $91.20 |
52-Week Low | $110.24 | $47.29 |
Enterprise Value | $43.55B | $4.50B |
Dividend Yield | 0.69% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $145.97, up 3.28% in the last session, with a bullish technical outlook from moving averages but overbought RSI levels. The company reported strong Q1 2026 earnings, beating estimates with EPS of $1.49, and maintains solid profitability with a net income margin of 19.55%. Recent developments include FDA and EU approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its healthcare portfolio.
The stock offers upside to the consensus price target of $154.90, supported by analyst optimism (77.5% buy ratings), but high valuation ratios like a P/E of 146.56 pose risks. Investors should monitor execution of growth initiatives and competitive pressures in the life sciences sector, with earnings on August 26, 2026, as a key catalyst.
Tidewater (TDW) trades at $82.84, up 1.56% today, with a bullish technical signal from moving averages and strong support at $81. The company reported Q2 2026 EPS of $0.43, beating estimates, but has missed expectations in recent quarters. Revenue for 2025 was $1.35B with a net income margin of 18.34%, though 2026 projections show a decline to $1.3B and lower margins. Analyst consensus is mixed with 26.92% buy ratings, while institutional holdings saw increases from First Trust Advisors and Bank of New York Mellon in 2026.
Outlook: TDW benefits from operational strength and bullish technicals, but earnings misses and margin compression pose risks. Investors should weigh solid cash flow against competitive and macroeconomic headwinds in the oil and gas sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About Tidewater Inc
Tidewater is the leading global provider of offshore support vessels (OSVs) to the energy industry. With the world's largest fleet of platform supply vessels (PSVs) and anchor handling tugs (AHTS), it provides critical logistics and marine support for offshore oil, gas, and renewable energy projects. Following a period of massive strategic consolidation, Tidewater is now focused on maximizing day rates and free cash flow in a supply-constrained market, positioning itself as a primary beneficiary of the multi-year offshore upcycle.
Read more on TDW →
